2007
DOI: 10.1016/j.arthro.2007.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Extended-Duration Thromboprophylaxis With Enoxaparin After Arthroscopic Surgery of the Anterior Cruciate Ligament: A Prospective, Randomized, Placebo-Controlled Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
95
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 88 publications
(100 citation statements)
references
References 24 publications
3
95
0
2
Order By: Relevance
“…5,12,23,24 Nonetheless, the 2012 American College of Chest Physicians guidelines recommend no routine use of thromboprophylaxis in knee arthroscopy patients other than early mobilization (grade 2B). For patients with "additional thromboembolic risk factors or following a complicated procedure," however, thromboprophylaxis with LMWH is recommended (grade 1B).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…5,12,23,24 Nonetheless, the 2012 American College of Chest Physicians guidelines recommend no routine use of thromboprophylaxis in knee arthroscopy patients other than early mobilization (grade 2B). For patients with "additional thromboembolic risk factors or following a complicated procedure," however, thromboprophylaxis with LMWH is recommended (grade 1B).…”
Section: Discussionmentioning
confidence: 97%
“…Currently, the reported incidence of VTEs without thromboprophylaxis after knee arthroscopy ranges from 0.6% to 18%, depending on the diagnostic method used. [2][3][4][5][6] Most published studies have included relatively small numbers of patients and provided few risk factors for these events, [7][8][9] making it difficult to create definitive guidelines for thromboprophylaxis in knee arthroscopy patients. Nonetheless, there are classic risk factors for the development of VTEs described in the literature.…”
mentioning
confidence: 99%
“…This may or may not be attributed to our approach of all patients [31,32,54]. In a randomized trial evaluating the rate of VTE with the use of LMWH after ACL reconstruction, Marlovits et al [28] had a reduced rate of VTE in the treatment group of 2.8% compared with 41.2% in the placebo group, but it is important to note that all their patients were screened for VTE. Despite the nature of the multiligamentous knee reconstruction being more complex and time-consuming than a standard arthroscopic ACL reconstruction, rates of symptomatic VTE appear similar between multiligamentous knee reconstruction with routine use of thromboprophylaxis and ACL reconstruction groups, which generally were managed without it.…”
Section: Discussionmentioning
confidence: 99%
“…Zur Dauer der Prophylaxe ist zu sagen, dass nur wenige vergleichenden Studien mit unterschiedlicher Dauer durchgeführt wurden [45]. Die deutsche S 3-Leitlinie gibt eine konkrete Empfehlung für die Dauer mit einem Empfehlungsgrad mittlerer Stärke ("sollte"), die unten aufgeführt ist.…”
Section: Studienübersicht: Doak Und Ktepunclassified